NCT03228043 2024-11-14Apatinib for Resectable Colorectal CancerNanchong Central HospitalPhase NA Withdrawn
NCT03222089 2018-03-27Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRCFujian Cancer HospitalPhase 2 Withdrawn